Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2024-01-11 00:00:00 ET · period of report 2024-01-09 · accession 0001373585-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-11 | 2024-01-09 | LSTA | BROWN GREGORY B | Dir | A - Grant | $0.00 | +19.5K | 49.4K | +65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-09 | A | A | 19,480 | $0.00 | 49,414 | D | — | — | (F1) Represents 19,480 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2025. (F2) Includes 19,480 unvested restricted stock units. |